Cargando…
Bone Morphogenetic Protein 2 Promotes Bone Formation in Bone Defects in Which Bone Remodeling Is Suppressed by Long-Term and High-Dose Zoledronic Acid
The use of long-term and high-dose bisphosphate is associated with severely suppressed bone turnover and the delayed union of fractures. However, therapeutic methods to overcome the negative effects of bisphosphonate use are lacking. Bone morphogenetic proteins (BMPs) are powerful osteoinductive pro...
Autores principales: | Moon, Young Jae, Jeong, Seongyup, Lee, Kwang-Bok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854702/ https://www.ncbi.nlm.nih.gov/pubmed/36671658 http://dx.doi.org/10.3390/bioengineering10010086 |
Ejemplares similares
-
Topical co‐administration of zoledronate with recombinant human bone morphogenetic protein-2 can induce and maintain bone formation in the bone marrow environment
por: Ueyama, Hideki, et al.
Publicado: (2021) -
Effect of bone morphogenetic protein-2/hydroxyapatite on ankle fusion with bone defect in a rabbit model: a pilot study
por: Dang, Le Hoang Nam, et al.
Publicado: (2020) -
Bone morphogenetic proteins in destructive and remodeling arthritis
por: Lories, Rik JU, et al.
Publicado: (2007) -
Evaluation of bone formation using recombinant human bone morphogenetic proteins-7 in small maxillofacial bony defects
por: Anand, Vaibhav, et al.
Publicado: (2019) -
Bone structure and remodelling in stroke patients: Early effects of zoledronate()
por: Poole, Kenneth E.S., et al.
Publicado: (2009)